Though not positively aligned with a rising long-term interest rate environment, maybe BioPharma has anticipated the bump in yields and bottomed. We'll see. But one stock we've tracked in the…
As to the post's title, I have no idea. What I do know is that a nice profit is in the books on a suddenly overbought GILD off of Tuesday's…
Two earnings reports, two directional moves on things I hold. Luckily, Thing 1 is moving more than Thing 2 and other items are positive to boot. Subscribe to NFTRH Premium…
Personally, I am leaning slightly toward bearish on the stock market, but the Biotech sector has been going to its own beat. Taken in a vacuum, Gilead has an interesting…